In a retrospective cohort study, ustekinumab and guselkumab show trends toward lower risk for herpes zoster in patients with ...

Patients with hidradenitis suppurativa are at increased risk of developing several common inflammatory arthropathies in the years following diagnosis.

Department of Medicine, University of Toronto, Women's College Hospital, and co-authors have found biologics targeting ...

Interleukin-23 inhibitors may be able to reduce the risk of developing psoriatic arthritis among patients with psoriasis, ...

Patients with juvenile idiopathic arthritis (JIA) who carried the HLA-B27 genetic marker tended to have worse long-term ...

Axial involvement is present in approximately 25% of patients with PsA, with enthesitis, inflammatory bowel disease, and ...

Switching to an anti-inflammatory diet could significantly reduce arthritis symptoms in just eight weeks, according to Dr. Tamiko Katsumoto. Focusing on whole food, plant-based diets and ...

More than half of patients with psoriatic arthritis (PsA ... cytokines directly affects development and progression of arthritis, enthesitis, psoriasis, and dactylitis. In a phase II randomized ...

While no arthritis cure exists, speak with your doctor about medications and lifestyle changes. During menopause, estrogen production slows, which you may need to support bone and joint health.

Bimekizumab-bkzx is aiming to set a new standard for treatment success, and our belief in its innovative dual inhibition approach is reflected in our dedication to head-to-head trials, including the ...

Most common (≥ 2%) adverse reactions in psoriatic arthritis include upper respiratory tract infections, oral candidiasis, headache, diarrhea, and urinary tract infections. Most common (≥ 2% ...